Uçkay Ilker, Garbino Jorge, Dietrich Pierre-Yves, Ninet Béatrice, Rohner Peter, Jacomo Véronique
Division of Infectious Diseases, Department of Medicine, University Hospital of Geneva, Switzerland.
BMC Infect Dis. 2006 May 23;6:86. doi: 10.1186/1471-2334-6-86.
Helicobacter cinaedi is a rare pathogen in humans, occurring mostly in immuno-compromised patients, with a high potential for recurrence. We describe a case of a patient with lymphoma hospitalized for chemotherapy.
At admission, the patient presented with an indolent and non-prurigenic macular rash around her implantable venous access device. Gram staining of blood cultures revealed the presence of spiral-shaped gram-negative rods that could not be grown upon subculture. Helicobacter cinaedi was identified by PCR. No other symptoms or pathology were observed in a whole body CT scan. The implantable venous access device was removed and empiric therapy by ceftriaxone and gentamicin for 2 weeks was initiated, followed by peroral clarithromycin 2 x 500 mg/day and later by levofloxacin 2 x 500 mg/day for 7 weeks. Oncologic remission was achieved 3 months later. However, the patient was re-hospitalized 2 months later for fever, shivering, reappearance of the macular non-prurigenic rash, diarrhea, cough and asthenia. Blood cultures grew H. cinaedi. Multiple investigations could not identify the source. Empiric antibiotic therapy of ceftriaxone and doxycycline was started for 2 weeks with resolution of symptoms, followed by an oral combination of amoxicillin, metronidazole and doxycycline for 2 months; doxycycline was continued for another month. Bacteremia has not recurred for a period of 19 months.
Although H. cinaedi is considered to be a low virulent bacteria, its potential to cause recurrent bacteremia should not be underestimated. H. cinaedi could have an endovascular source of infection and should be treated for an adequate duration with combined antibiotherapy.
嗜人栖热螺杆菌是人类罕见的病原体,主要发生在免疫功能低下的患者中,复发可能性高。我们描述了一例因化疗住院的淋巴瘤患者。
入院时,患者在其植入式静脉通路装置周围出现无痛性、非瘙痒性黄斑疹。血培养革兰氏染色显示存在螺旋形革兰氏阴性杆菌,传代培养无法生长。通过聚合酶链反应鉴定为嗜人栖热螺杆菌。全身CT扫描未观察到其他症状或病变。移除植入式静脉通路装置,开始用头孢曲松和庆大霉素进行经验性治疗2周,随后口服克拉霉素2×500mg/天,之后口服左氧氟沙星2×500mg/天,持续7周。3个月后实现肿瘤缓解。然而,患者在2个月后因发热、寒战、黄斑非瘙痒性皮疹再现、腹泻、咳嗽和乏力再次住院。血培养生长出嗜人栖热螺杆菌。多项检查未能确定来源。开始用头孢曲松和强力霉素进行经验性抗生素治疗2周,症状缓解,随后口服阿莫西林、甲硝唑和强力霉素联合用药2个月;强力霉素继续服用1个月。19个月期间菌血症未复发。
虽然嗜人栖热螺杆菌被认为是低毒力细菌,但其引起复发性菌血症的可能性不应被低估。嗜人栖热螺杆菌可能有血管内感染源,应采用联合抗生素治疗足够疗程。